Neural and Mobile Assessment OF Behavior Change Among Problem Drinkers
NCT ID: NCT03457077
Last Updated: 2023-07-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
164 participants
INTERVENTIONAL
2018-02-27
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neural Mechanisms of Disulfiram Effects
NCT02735577
Alcohol, Behavior, and Brain Imaging
NCT03930446
The Effect of Positive and Negative Emotions on Brain Activity in Alcoholics and Nonalcoholics
NCT00001675
Reducing Alcohol Use in Depressed Patients
NCT00183079
Training Inhibition in Alcohol Use Disorder
NCT03530384
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Brief Intervention
Participants will receive a brief intervention at week 0
Brief intervention
A brief motivational intervention with feedback about drinking levels compared to norms
Delayed Intervention
Participants will receive a brief intervention at 6 months
Brief intervention
A brief motivational intervention with feedback about drinking levels compared to norms
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Brief intervention
A brief motivational intervention with feedback about drinking levels compared to norms
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English language fluency
* Over the last 28 days ,Have an average weekly consumption of greater than 14 standard drinks for women, and greater than 24 standard drinks for men.
* Current DSM-V mild or moderate alcohol use disorder (AUD) diagnosis
* Own a smartphone with data plan
* Age 21-55
* English language fluency
* Have an average weekly consumption of less than \</=14 standard drinks for women and less than/equal to 24 standard drinks for men and up to 2 heavy drinking days (\>4/5 standard drinks for a woman/man)
* No lifetime diagnosis of AUD
* owns smartphone with a data plan
Exclusion Criteria
* Currently seeking treatment or attempting to stop drinking
* Past or current alcohol withdrawal symptoms
* Current DSM-V diagnosis of substance use disorder (other than nicotine or caffeine).
* Regular use (more than 1-2 times weekly) of recreational drugs.
* Psychotic Disorder or Bipolar disorder
* Severe depression (Patient Health Questionnaire score \> 19) or anxiety (Beck Anxiety Inventory \> 25)
* Substantial risk of suicide or violence
* MRI contraindications (e.g., metallic implants, pacemaker, weight \> 350 lbs, waist \> 55")
* Hearing impaired/hearing aids, unable to read newspaper at arm's length with corrective
* Objective cognitive impairment
* Current or recent (evidence of disease x 5 years) non-skin neoplastic disease or melanoma. - Active hepatic disease (not a history of hepatitis) or primary renal disease requiring dialysis, primary untreated endocrine diseases, e.g., Cushing's disease or primary hypothalamic failure or insulin dependent diabetes (Type I or II). Well-treated hypothyroidism will not be excluded.
* Pregnant, lactating (participation allowed 3 months after ceasing lactation), or currently intending to become pregnant
* Any history of ECT
* Brain disorder such as stroke, tumor, infection, epilepsy, multiple sclerosis, degenerative diseases, head injury (LOC \> 5 minutes), mental retardation
* Diagnosed learning disability, dyslexia, or ADHD
* For women: Current pregnancy or intention to be pregnant in the near future
21 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northwell Health
OTHER
New York State Psychiatric Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nasir Naqvi
research psychiatrist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nasir Naqvi, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Columbia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NYPInstitute
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
7390
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.